NeoCore Technology Co

NeoCore Technology Co ROE

The Return on Equity (ROE) of NeoCore Technology Co (4131.TWO) as of Nov 11, 2026 is -15.78 %. In the previous year, Return on Equity (ROE) was -18.59 % — a change of -15.14% (higher).

ROE

-15.78 %

YoY

-15.14%

Last updated:

In 2024, NeoCore Technology Co's return on equity (ROE) was -15.78 %, a -15.14% increase from the -18.59 % ROE in the previous year.

The NeoCore Technology Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2017
-18.17 TWD
Jan 1, 2018
-15.48 TWD
Jan 1, 2019
-7.91 TWD
Jan 1, 2020
-20.96 TWD
Jan 1, 2021
-15.35 TWD
Jan 1, 2022
-37.16 TWD
Jan 1, 2023
-18.59 TWD
Jan 1, 2024
-15.78 TWD
The NeoCore Technology Co ROE history
YEARROEYoY
-15.78 %-15.14%
-18.59 %-49.96%
-37.16 %+142.12%
-15.35 %-26.79%
-20.96 %+165.15%
-7.91 %-48.93%
-15.48 %-14.79%
-18.17 %-9.28%
-20.03 %+92.77%
-10.39 %-11.71%
-11.77 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeoCore Technology Co Stock analysis

What does NeoCore Technology Co do? NeoCore Technology Co Ltd generates revenue through the sale of biochips and related biotechnology products. The company develops and manufactures DNA/RNA sample preparation kits, polymerase chain reaction kits, rapid hybridization equipment, biochips, testing reagents, biological preparations, nucleic acid sequencing detection systems, biotechnology control hardware and software, and biomedical materials. These products are primarily sold within Taiwan and exported to Asian and European markets. The company's domestic sales focus on the Taiwanese market while international exports target Asian and European customers. DR. Chip Biotechnology, Inc. operates as the parent company for NeoCore Technology Co Ltd, managing the research, development, manufacturing, and sales of biochips. The business model relies on direct sales of its comprehensive product portfolio to domestic and international clients in the biotechnology sector. The company's product range serves both laboratory and commercial applications within the biotechnology industry. NeoCore Technology Co Ltd's revenue streams include the sale of biochips, DNA/RNA sample preparation kits, polymerase chain reaction kits, and related components. The company's export focus on Asia and Europe drives international sales, while domestic sales in Taiwan form a significant portion of its business. The company's product offerings cater to the needs of biotechnology laboratories and commercial entities requiring advanced biotech solutions. NeoCore Technology Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding NeoCore Technology Co's Return on Equity (ROE)

NeoCore Technology Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing NeoCore Technology Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

NeoCore Technology Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in NeoCore Technology Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about NeoCore Technology Co stock

Return on Equity (ROE) of NeoCore Technology Co is -15.78 % in 2024.

Return on Equity (ROE) of NeoCore Technology Co changed from -18.59 % to -15.78 %, representing a -15.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) NeoCore Technology Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s NeoCore Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — NeoCore Technology Co

All Key Metrics — NeoCore Technology Co